Cargando…
Ficolin B in Diabetic Kidney Disease in a Mouse Model of Type 1 Diabetes
Background. The innate immune system may have adverse effects in diabetes and cardiovascular disease. The complement system seems to play a key role through erroneous complement activation via hyperglycaemia-induced neoepitopes. Recently mannan-binding lectin (MBL) was shown to worsen diabetic kidne...
Autores principales: | Holt, Charlotte Berg, Østergaard, Jakob Appel, Axelgaard, Esben, Nielsen, Gitte Krogh, Endo, Yuichi, Thiel, Steffen, Hansen, Troels Krarup |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539181/ https://www.ncbi.nlm.nih.gov/pubmed/26339138 http://dx.doi.org/10.1155/2015/653260 |
Ejemplares similares
-
Diabetes Is Associated with Increased Autoreactivity of Mannan-Binding Lectin
por: Axelgaard, Esben, et al.
Publicado: (2017) -
Global Autorecognition and Activation of Complement by Mannan-Binding Lectin in a Mouse Model of Type 1 Diabetes
por: Axelgaard, Esben, et al.
Publicado: (2017) -
The pattern-recognition molecule H-ficolin in relation to diabetic kidney disease, mortality, and cardiovascular events in type 1 diabetes
por: Østergaard, Jakob Appel, et al.
Publicado: (2021) -
Effect of Optimization of Glycaemic Control on Mannan-Binding Lectin in Type 1 Diabetes
por: Dørflinger, Gry Høst, et al.
Publicado: (2017) -
Mannan-Binding Lectin in Diabetic Kidney Disease: The Impact of Mouse Genetics in a Type 1 Diabetes Model
por: Østergaard, Jakob Appel, et al.
Publicado: (2012)